A study published on Frontiers in Immunology showed for the first time the preclinical activity of the novel Precision Biologics monoclonal antibody NEO-201 as a possible therapeutic agent for the treatment of a broad variety of human carcinomas. https://t
32 followers
981 followers
RT @FrontImmunol: Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas: Massimo Fantin…
641 followers
RT @FrontImmunol: Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas: Massimo Fantin…
32,225 followers
Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas: Massimo Fantini, Justin M. David, Olga Saric, Alexander Dubeykovskiy, Yongzhi Cui, Sharon A. Mavroukakis, Andrew Bristol, Christina M. Annunziata,… h